Triggering final follicular maturation- hCG, GnRH-agonist or both, when and to whom?

Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates

(2014) Daniel Griffin et al.   FERTILITY AND STERILITY

Co-administration of GnRH-agonist and hCG, for final oocyte maturation (double trigger), in patients with low proportion of mature oocytes

(2014) Eran Zilberberg et al.   GYNECOLOGICAL ENDOCRINOLOGY

HCG (1500IU) administration on day 3 after oocytes retrieval, following GnRH-agonist trigger for final follicular maturation, results in high sufficient mid luteal progesterone levels - a proof of concept

(2014) Jigal Haas et al.   Journal of Ovarian Research

Co-administration of GnRH-agonist and hCG for final oocyte maturation (double trigger) in patients with low number of oocytes retrieved per number of preovulatory follicles-a preliminary report

(2014) Jigal Haas et al.   Journal of Ovarian Research

Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles

(2013) Ming-Huei Lin et al.   FERTILITY AND STERILITY

Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG

(2013) A. Seyhan et al.   HUMAN REPRODUCTION

Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma

(2013) Raoul Orvieto   Journal of Ovarian Research

Empty follicle syndrome: successful treatment in a recurrent case and review of the literature

(2012) R. Beck-Fruchter et al.   HUMAN REPRODUCTION

LH and hCG Action on the Same Receptor Results in Quantitatively and Qualitatively Different Intracellular Signalling

(2012) Livio Casarini et al.   PLoS One

Comparison of “triggers” using leuprolide acetate alone or in combination with low-dose human chorionic gonadotropin

(2011) Bruce S. Shapiro et al.   FERTILITY AND STERILITY

An OHSS-Free Clinic by segmentation of IVF treatment

(2011) P. Devroey et al.   HUMAN REPRODUCTION

ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria

(2011) A. P. Ferraretti et al.   HUMAN REPRODUCTION

The time interval between hCG priming and oocyte retrieval in ART program: a meta-analysis

(2011) Wei Wang et al.   JOURNAL OF ASSISTED REPRODUCTION AND GENETICS

The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives

(2011) Peter Humaidan et al.   REPRODUCTIVE BIOMEDICINE ONLINE

Gonadotropin-releasing hormone agonist or human chorionic gonadotropin for final oocyte maturation in an oocyte donor program

(2009) Teresa M. Erb et al.   FERTILITY AND STERILITY

1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study

(2009) Peter Humaidan et al.   FERTILITY AND STERILITY

Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization

(2007) Bruce S. Shapiro et al.   FERTILITY AND STERILITY